Medicine and Dentistry
In Vitro Fertilisation
100%
Health Care Cost
42%
Ovarian Hyperstimulation Syndrome
39%
Ectopic Pregnancy
35%
Gonadotropin-Releasing Hormone
30%
Follicle
30%
Postmenopause
30%
Diethylstilbestrol
30%
Primary Ovarian Insufficiency
30%
Androgen Therapy
30%
Autotransplantation
30%
Antral Follicle
30%
Cost-Effectiveness Analysis
30%
Gonadotropin
29%
Oocyte
19%
Side Effect
15%
Adverse Event
13%
Estrogen Therapy
12%
Urinary System
12%
Gonadorelin Antagonist
10%
Luteinization
10%
Malignant Neoplasm
9%
Hormone Synthesis
9%
Fertility Preservation
9%
Cancer Recurrence
9%
Superovulation
9%
Progesterone
9%
Androgen
7%
Meta-Analysis
7%
Transdermal Patch
7%
Biological Product
7%
Supplementation
7%
Physical Disease by Body Function
7%
Randomized Controlled Trial
7%
Quality of Life
7%
Ovariectomy
7%
First Pass Effect
7%
Clinician
6%
Pregnancy Rate
6%
Clomifene Citrate
6%
Pregnancy
6%
Assisted Reproductive Technology
6%
Fertilization
5%
Isoniazid
5%
Human Menopausal Gonadotropin
5%
Gonadorelin Agonist
5%
Prematurity
5%
Clinical Research
5%
Downregulation
5%
Birth Rate
5%
Keyphrases
Primary Ovarian Insufficiency
30%
Preantral Follicles
30%
Ovarian Hyperstimulation Syndrome
30%
46,XX
30%
High Responder
30%
Heterotopic Pregnancy
30%
Prospective Evaluation
30%
Follicle
24%
Estradiol Level
15%
Serum Estradiol Level
12%
Vaginal Progesterone
12%
Follicle Size
12%
Fertility Preservation Treatment
9%
Urinary Gonadotropins
9%
High Risk
9%
Highest Peak
9%
Ovarian Stimulation
9%
Oocyte number
9%
Peak Estradiol
9%
LH Suppression
9%
In Vitro Fertilization
9%
Implantation Rate
9%
Pregnancy Rate
9%
Antagonist Cycle
7%
Gonadotropin-releasing Hormone Antagonist
7%
Intramuscular Progesterone
7%
Human Infertility
7%
FSH Level
6%
Estrogen Replacement Therapy
6%
Multiple Injections
6%
FSH Receptor
6%
LH Level
6%
Minimal Stimulation
6%
Design Case
6%
Ovulatory Function
6%
Serum Estradiol
6%
Histologic
6%
Ultrasound
6%
Hepatic First-pass Metabolism
6%
National Institutes of Health
6%
Clinical Research Center
6%
Ovarian Follicle
6%
Progesterone Secretion
6%
Luteinization
6%
Late Start
5%
Extrauterine Pregnancy
5%
Riolan
5%
Recombinant Products
5%
Abcess
5%
10th Century
5%
Pharmacology, Toxicology and Pharmaceutical Science
Progesterone
52%
Diethylstilbestrol
45%
Gonadotropin
45%
Ovary Hyperstimulation
37%
Side Effect
30%
Superovulation
30%
Premature Ovarian Failure
30%
Gonadorelin Agonist
27%
Adverse Event
22%
Gonadorelin Antagonist
21%
First Pass Effect
15%
Androgen
15%
Biological Product
15%
Transdermal Patch
15%
Physical Disease by Body Function
15%
Ectopic Pregnancy
15%
Human Menopausal Gonadotropin
15%
Prematurity
15%
Randomized Controlled Trial
15%
Chorionic Gonadotropin
12%
Clinical Research
7%
Isoniazid
7%
Follitropin Receptor
7%
Clomifene Citrate
7%